SEC Form 4 · accession 0001615774-17-001104

Vivani Medical, Inc. · VANI

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chief Financial Officer

Period of report

Mar 14, 2017

Accepted (ET)

Mar 16, 2017 · 5:42 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001266806

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1	Mar 14, 2017	A	67,435	$1.47	A	78,354	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Warrant to Purchase Common Stock^F1	$1.47	Mar 14, 2017	A	67,435	A	Mar 14, 2017	Mar 14, 2022	Common Stock	67,435	67,435	D
Non-Qualified Stock Option (right to buy)^F2	$1.97	holding	—	—	—	Jan 3, 2018	Jan 3, 2027	Common Stock	181,980	181,980	D
Non-Qualified Stock Option (right to buy)^F2	$4.10	holding	—	—	—	Jan 21, 2017	Jan 21, 2026	Common Stock	38,225	38,225	D
Non-Qualified Stock Option (right to buy)^F3	$7.00	holding	—	—	—	Aug 1, 2015	Aug 1, 2024	Common Stock	175,000	175,000	D
Non-Qualified Stock Option (right to buy)^F3	$13.09	holding	—	—	—	Mar 25, 2016	Mar 25, 2025	Common Stock	12,907	12,907	D

F1Common stock and warrants reported on this Form 4 pursuant to an exercise of subscription rights previously distributed by the Company to all holders of the Company's common stock. Each stockholder received a right to invest $0.47 for every share held of record on February 10, 2017, the record date, to purchase units consisting of one share of common stock and one warrant to purchase one share of common stock. The final allocation numbers of units were distributed on March 14, 2017.
F2Options vest over a four year term of which one-fourth vests on the Date Exercisable, with the remaining options vesting quarterly over three years thereafter.
F3Options vest in 4 yearly increments starting with the Date Exercisable